Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Becton, Dickinson and Company BDX
$251.41
На 18:00, 12 мая 2023
+9.78%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
71412733612.00000000
-
week52high
269.06
-
week52low
215.90
-
Revenue
18870000000
-
P/E TTM
45
-
Beta
0.56297500
-
EPS
5.17000000
-
Last Dividend
3.64000000
-
Next Earnings Date
04 мая 2023 г. в 12:00
Описание компании
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Buy | Buy | 16 авг 2022 г. |
| Stifel | Buy | Buy | 18 июл 2022 г. |
| Morgan Stanley | Overweight | Overweight | 15 июл 2022 г. |
| Citigroup | Sell | Neutral | 11 июл 2022 г. |
| Wells Fargo | Overweight | Equal-Weight | 24 июн 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Piper Sandler | Neutral | Neutral | 11 ноя 2022 г. |
| Goldman Sachs | Buy | Buy | 23 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 06 янв 2023 г. |
| B of A Securities | Buy | Neutral | 03 янв 2023 г. |
| Citigroup | Neutral | Sell | 12 дек 2022 г. |
| Piper Sandler | Neutral | Neutral | 03 февр 2023 г. |
| Morgan Stanley | Overweight | Overweight | 03 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Byington Carrie L | A | 548 | 106 | 02 февр 2023 г. |
| Jones Christopher Ian Montague | A | 9086 | 205 | 02 февр 2023 г. |
| Fraser Claire | A | 22311 | 848 | 26 янв 2023 г. |
| RING TIMOTHY M | A | 78830 | 848 | 24 янв 2023 г. |
| SCOTT BERTRAM L | A | 33779 | 848 | 24 янв 2023 г. |
| Henderson Jeffrey William | A | 4653 | 848 | 24 янв 2023 г. |
| Jones Christopher Ian Montague | A | 29171 | 848 | 24 янв 2023 г. |
| LARSEN MARSHALL O | A | 28919 | 848 | 24 янв 2023 г. |
| BURZIK CATHERINE M | A | 13425 | 848 | 24 янв 2023 г. |
| ECKERT R ANDREW | A | 6992 | 848 | 24 янв 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Fundsmith LLP | 4328550 | -6321 | 30 июн 2021 г. |
| Vanguard Total Stock Market Index Fund | 8308750 | -73015 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 6059080 | -22120 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 3092250 | -14774 | 31 авг 2020 г. |
| Fidelity Select Medical Technology and Devices Portfolio | 2670000 | 110000 | 31 июл 2020 г. |
| Fidelity 500 Index Fund | 2626610 | -2843 | 31 июл 2020 г. |
| Vanguard Wellington Fund | 5342620 | 346589 | 30 июн 2020 г. |
| T. Rowe Price Capital Appreciation Fund | 4110430 | 1664270 | 30 июн 2020 г. |
| MS INVF Global Brands | 2811560 | 638907 | 30 июн 2020 г. |
| Franklin Rising Dividends Fund | 2703160 | 0 | 30 июн 2020 г. |
Новостная лента
Becton Dickinson CEO: Q2 ‘was another quarter of exceeding expectations'
Yahoo Finance
04 мая 2023 г. в 15:45
Becton, Dickinson and Company CEO and President Tom Polen joins Yahoo Finance Live to discuss company earnings, growth opportunities in the home test kit market, biotech drugs, strong demand in the weight loss market, and the outlook for Becton Dickinson.
BD (BDX) Q2 Earnings Surpass Estimates, FY23 View Revised
Zacks Investment Research
04 мая 2023 г. в 12:12
BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal second quarter.
BD (BDX) Gears Up for Q2 Earnings: What's in the Offing?
Zacks Investment Research
03 мая 2023 г. в 15:13
Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q2 sales.
Becton, Dickinson and Company: This Serial-Acquirer Is A Buy
Seeking Alpha
15 апр 2023 г. в 09:35
The medical devices industry has grown steadily for many decades, driven by people living longer and increased adoption of technologically advanced healthcare devices. Given the predictability of the revenues, this industry lends itself well to industry consolidators who can deploy excess free cash flow into additional revenue streams.
BDX vs. WST: Which Stock Is the Better Value Option?
Zacks Investment Research
14 апр 2023 г. в 12:55
Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Becton Dickinson (BDX) and West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?